ASX Announcements

NOX makes strategic commitment to treatment of rare cancers
Noxopharm Mid Year Investor Briefings
Market Guidance for Next Six Months
Appendix 4C - quarterly
FNN Interview with NOX CEO Explaining Idronoxil-C Discovery
NOX Files Patent Application on 'Smart' Idronoxil
Appendix 3B
NOX and Monash Uni Collaboration Receives Federal Grant
Noxopharm and UNSW combine on stroke project
Gold Coast Qld Mid-Year Briefing Details